Noveris Health Sciences is trading 6% down at CA$0.39 after a highly volatile stretch.

  • The stock rebounded 20.29% on August 10, 2026, following steep declines earlier in the week.
  • No company-specific announcement explaining the August 11, 2026 decline was found.
  • Management said on August 6 it was unaware of any material operational change accounting for the recent market activity, while broader markets remained largely flat.